We are grateful for the generous support of our Annual Meeting partners!
The event has been supported by UiO:Life Science. UiO:Life Science is one of the University of Oslo’s three interdisciplinary initiatives and aims to strengthen quality and interaction in research; recruit, educate and develop talents; and promote innovation in the life sciences related to environment and health.
AbbVie is a research-driven biopharma company with the mission to discover, develop and deliver new innovative medicines that solve severe health challenges today and tomorrow. We focus on Immunology, Neuroscience, Oncology and other specialties. AbbVie is headquartered in Chicago with presence in 175 countries with 57 000 employees. In Scandinavia, we are 300 employees with offices in Stockholm, Oslo and Copenhagen. In all three countries, we are ranked as a top employer by Great Place to Work.
AstraZeneca Norway is part of AstraZeneca, a global, research-driven biopharmaceutical company focused on the research, development, and provision of medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolic diseases, as well as respiratory and immunology. AstraZeneca is headquartered in Cambridge, United Kingdom, and the company’s medicines are sold in more than 125 countries and used by millions of patients worldwide. AstraZeneca Norway is part of AstraZeneca Nordic, with its Nordic headquarters in Stockholm, and has its Norwegian headquarters in Oslo. In Norway, the company has around 100 employees.
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are motivated by the power of science, with a legacy of pursuing bold science across oncology, hematology, cardiovascular, immunology, and neuroscience. We’re accelerating the development of new medicines with differentiated research platforms and leading technology to define what’s possible for the future of medicine and the patients we serve.
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Twitter, LinkedIn and YouTube.
The Research Council’s aim is to promote a society where research is created, used and shared, and thus contributes to restructuring and enhanced sustainability.
Roche is a healthcare company uniquely placed to prevent, stop and cure diseases by uniting leading science and technology across diagnostics, medicines and digital solutions.
Roche was founded in Basel, Switzerland in 1896 and today is a leading provider of transformative medicines and diagnostics for millions of people in over 150 countries around the world. It is dedicated to tackling healthcare challenges that place the greatest strain on patients, families, communities and healthcare systems. Across its Diagnostics and Pharmaceutical divisions, Roche focuses on areas including oncology, neurology, cardiovascular and metabolic diseases, ophthalmology, infectious diseases and immunology with the aim of providing real and positive change for patients, the people they love and the professionals who care for them.
Genentech in the United States is a fully owned subsidiary in the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, a major innovator in the Japanese therapeutic antibody market.
At UCB, we believe that everyone deserves to live the best life that they can. That’s why – as a global biopharmaceutical leader – we’re focused on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions.